CAR T Cell Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
Phase 2
25
about 5.9 years
≤21
1 site in TN
What this study is about
This trial is testing a new treatment called CAR T cell therapy for people with leukemia that has returned or not responded to other treatments. The treatment involves modifying immune cells to fight cancer cells. Researchers are looking at different doses of chemotherapy drugs, how the body processes these drugs, and how long the CAR T cells last in the body.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive CD19-CAR T cell Infusion
- 2.Take Cyclophosphamide
- 3.Take Fludarabine
- +1 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
cell therapy, cyclophosphamide (Alkylating chemotherapy; crosslinks DNA strands), fludarabine, mesna
infusion, oral (Oral Tablet)
Primary: Fludarabine Pharmacokinetics
Oncology